Table 2

Univariable linear regression with TSK-NL Heart as dependent variable (N=149)

Variable	Standardised beta (95% CI)	Adjusted R²	P value
Demographics
Age (continuous)	−0.13 (−0.29 to 0.04)	0.001	0.13
Age ≤50	0.22 (0.38 to 2.49)	0.05	0.008
Female sex	0.19 (0.03 to 0.35)	0.03	0.02
Higher education	−0.24 (−0.40 to −0.08)	0.05	0.003
Index event
Acute coronary syndrome	0.08 (−0.08 to 0.25)	0.001	0.31
Stable angina revascularisation	−0.04 (−0.21 to 0.12)	−0.001	0.61
Atrial fibrillation	−0.04 (−0.21 to 0.12)	−0.001	0.59
Admission
Acute admission	0.07 (−0.09 to 0.24)	0.001	0.37
Treatment index event
PCI	0.02 (−0.14 to 0.19)	−0.01	0.79
ECV	−0.02 (−0.19 to 0.14)	−0.01	0.99
Medication only	−0.01 (−0.16 to 0.16)	−0.01	0.99
Cardiac disease history
Acute coronary syndrome	−0.08 (−0.25 to 0.08)	0.001	0.32
PCI	0.001 (−0.16 to 0.16)	−0.001	0.49
CABG	0.06 (−0.10 to 0.22)	−0.001	0.46
Stroke	−0.11 (−0.28 to 0.49)	0.001	0.17
Peripheral artery disease	0.03 (−0.13 to 0.20)	−0.001	0.40
CVD risk factors
Diabetes mellitus	−0.02 (−0.18 to 0.15)	−0.001	0.83
History of hypertension	0.03 (−0.13 to 0.20)	−0.01	0.69
History of dyslipidaemia	0.08 (−0.09 to 0.24)	−0.001	0.35
BMI	0.14 (−0.19 to 0.30)	0.01	0.08
Psychological risk factors
GSES	−0.18 (−0.34 to −0.02)	0.03	0.03
HADS anxiety	0.27 (0.11 to 0.42)	0.06	0.001
HADS depression	0.32 (0.16 to 0.47)	0.09	0.001
IMSA biological complexity	0.21 (0.06 to 0.37)	0.04	0.009
IMSA psychological complexity	0.32 (0.17 to 0.48)	0.10	0.001
IMSA social complexity	0.33 (0.17 to 0.48)	0.10	0.001
CAQ cardiac anxiety	0.42 (0.27 to 0.57)	0.17	0.001

BMI, body mass index; CABG, coronary artery bypass grafting; CAQ, Cardiac Anxiety Questionnaire; CVD, cardiovascular disease; ECV, electrocardioversion; GSES, General Self-Efficacy Scale; HADS, Hospital Anxiety and Depression Scale; IMSA, InterMed Self-Assessment; PCI, percutaneous coronary intervention; TSK-NL Heart, Tampa Scale for Kinesiophobia.